These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7274047)

  • 41. Post-conceptional induction of menses with a single vaginal suppository of (15S)-15-methyl prostaglandin F2 alpha methyl ester.
    Scher J; Jeng DY; Kerenyi TD
    Prostaglandins; 1980 Sep; 20(3):469-79. PubMed ID: 6252575
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acceptability of five nonoxynol-9 spermicides.
    Raymond EG; Chen PL; Condon S; Luoto J; Barnhart KT; Creinin MD; Poindexter A; Wan L; Martens M; Schenken R; Blackwell R
    Contraception; 2005 Jun; 71(6):438-42. PubMed ID: 15914133
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The saga of Encare Oval: an FDA advisory panel at work.
    Lohr L
    Am Pharm; 1978 Aug; 18(9):20-4. PubMed ID: 677008
    [No Abstract]   [Full Text] [Related]  

  • 44. Inadvertent urethral insertion of a contraceptive suppository.
    Pliskin MJ; Dresner ML
    J Urol; 1988 May; 139(5):1049-50. PubMed ID: 2834568
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A phase I comparative study of three contraceptive vaginal films containing nonoxynol-9. Postcoital testing and colposcopy.
    Mauck CK; Baker JM; Barr SP; Johanson WM; Archer DF
    Contraception; 1997 Aug; 56(2):97-102. PubMed ID: 9315418
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Animal experiments and clinical studies on spermicidal vaginal films and suppositories containing surface active alkylpolyethoxyphenoxyethanol (author's transl)].
    Diao XH
    Zhonghua Fu Chan Ke Za Zhi; 1982 Apr; 17(2):80-3. PubMed ID: 7105913
    [No Abstract]   [Full Text] [Related]  

  • 47. Contraceptive efficacy and safety of HerbOshield™ vaginal gel in rats.
    Singh KK; Parmar S; Tatke PA
    Contraception; 2012 Jan; 85(1):122-7. PubMed ID: 22067802
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Vaginal contraception in 1982. Realities and perspectives (author's transl)].
    Limouzin-lamothe MA
    Contracept Fertil Sex (Paris); 1982 Nov; 10(11):759-69. PubMed ID: 12311810
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acrosin inhibitor, 4'-acetamidophenyl 4-guanidinobenzoate, an experimental vaginal contraceptive with anti-HIV activity.
    Bourinbaiar AS; Lee-Huang S
    Contraception; 1995 May; 51(5):319-22. PubMed ID: 7628208
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Termination of early pregnancy by a single-dose 3.0 mg 15-methyl PGF2alpha methyl ester vaginal suppository.
    Mandelin M
    Prostaglandins; 1978 Jul; 16(1):143-52. PubMed ID: 704921
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lea's Shield: a study of the safety and efficacy of a new vaginal barrier contraceptive used with and without spermicide.
    Mauck C; Glover LH; Miller E; Allen S; Archer DF; Blumenthal P; Rosenzweig A; Dominik R; Sturgen K; Cooper J; Fingerhut F; Peacock L; Gabelnick HL
    Contraception; 1996 Jun; 53(6):329-35. PubMed ID: 8773419
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Uterine rupture associated with the use of vaginal prostaglandin E2 suppositories.
    Keller F; Joyce TH
    Can Anaesth Soc J; 1984 Jan; 31(1):80-2. PubMed ID: 6581851
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Methods to determine success of attempts to terminate early gestation pregnancies with prostaglandin vaginal suppositories.
    Brenner PF; Marrs RP; Roy S; Mishell DR
    Contraception; 1983 Aug; 28(2):111-24. PubMed ID: 6196152
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Practical experience with a new vaginal contraceptive.
    Doring GK
    Int J Sexol; 1954 Nov; 8(2):93-4. PubMed ID: 12255499
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The vaginal contraceptive sponge.
    Edelman DA
    IPPF Med Bull; 1984 Jun; 18(3):1-2. PubMed ID: 12266284
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New developments in vaginal contraception.
    Popul Rep H; 1984; (7):H157-90. PubMed ID: 6321270
    [No Abstract]   [Full Text] [Related]  

  • 57. Acute urinary retention secondary to urethral inflammation from a vaginal contraceptive suppository in a 17-year-old boy.
    Saborio DV; Kennedy WA; Hoke GP
    Urol Int; 1997; 58(2):128-30. PubMed ID: 9096278
    [TBL] [Abstract][Full Text] [Related]  

  • 58. STD studies show spermicides protect against Chlamydia.
    Netw Res Triangle Park N C; 1986; 7(2):4. PubMed ID: 12340620
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of storage and temperature upon soft jelly capsules containing nonoxynol as spermicide.
    Recio R; Bassol S
    Contraception; 1995 Mar; 51(3):201-2. PubMed ID: 7621689
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A new iud insertion technique utilizing cervical priming with prostaglandin.
    Lauersen NH; Kurkulos M; Graves ZR; Leeds L
    Contraception; 1982 Jul; 26(1):59-63. PubMed ID: 7128135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.